Ophthalmic medical devices in India are regulated by CDSCO under the Medical Devices Rules, 2017 and classified into four risk classes — A, B, C, and D. Class A and Class B ophthalmic devices (such as visual charts, ophthalmoscopes, tonometers, and corneal instruments) require the MD5 manufacturing license via Form MD3 from the State Licensing Authority, with fees of Rs. 5,000 plus Rs. 500 per device. Class C and Class D ophthalmic devices (such as phacoemulsification systems, vitrectomy systems, excimer laser systems, corneal inlays, and aqueous humour replacement kits) require the MD9 manufacturing license via Form MD7 from the Central Licensing Authority, with fees of Rs. 50,000 plus Rs. 1,000 per device. Importers require the MD15 import license. Under GSR 102(E) dated 11 February 2020, Class C and D ophthalmic devices transitioned from registration to full licensing from 1 October 2023. All applications are filed on the SUGAM portal at cdscoonline.gov.in. Licenses are valid indefinitely with a five-year retention fee.
In 2026, the Indian ophthalmic medical device market is one of the fastest-growing segments of the country's healthcare device sector. Driven by a rapidly ageing population, rising rates of refractive error and diabetes-related eye disease, expanding cataract surgery volumes under government health schemes, and growing private investment in ophthalmic hospitals and vision centres, demand for ophthalmic instruments, surgical systems, and diagnostic equipment has never been higher.
For every manufacturer and importer operating in this market, CDSCO registration is a mandatory pre-condition. The regulatory framework under MDR 2017 is well-structured — but the pathway, form, fee, and authority all depend on where your specific ophthalmic device sits in CDSCO's four-class risk classification system. Understanding that classification before approaching the SUGAM portal is the single most important step in an efficient registration process.
📑 Quick Navigation
- What Are Ophthalmic Medical Devices?
- Market Opportunity in India 2026
- CDSCO Classification of Ophthalmic Medical Devices (Class A–D)
- Ophthalmic Device Examples by Class
- GSR 102(E): The Registration-to-Licensing Transition
- Licensing Pathways: MD5, MD9, and MD15
- Fee Structure
- Regulatory Framework at a Glance
- Document Checklist
- 7-Step CDSCO License Application Process
- Frequently Asked Questions
What Are Ophthalmic Medical Devices?
Ophthalmic medical devices are instruments, equipment, implants, and materials used by eye care professionals to diagnose, monitor, treat, and manage conditions of the eye and visual system. The category is broad and technically diverse — it includes simple diagnostic aids such as visual charts and ophthalmoscopes at one end, and complex surgical systems such as phacoemulsification platforms and femtosecond laser systems at the other.
CDSCO regulates ophthalmic medical devices under MDR 2017 because the eye is one of the most sensitive and vulnerable organs, and because ophthalmic procedures — particularly surgical ones — carry a direct risk to a patient's vision and quality of life if devices fail. A tonometer that measures intraocular pressure inaccurately can lead to missed or incorrect glaucoma diagnosis. A phacoemulsification system with inconsistent performance can compromise cataract surgery outcomes. A vitreous body prosthesis that is not biocompatible can trigger inflammatory responses that damage the retina. CDSCO's regulatory framework for ophthalmic devices is designed to ensure that every device entering the Indian market meets the safety and performance standards that patients and clinicians depend on.
Market Opportunity for Ophthalmic Medical Devices in India 2026
CDSCO Classification of Ophthalmic Medical Devices (Class A–D)
CDSCO classifies all ophthalmic medical devices into four risk-based classes under MDR 2017. The class of your device determines the license you need, the authority you apply to, the fee you pay, and the technical depth of documentation required. Verifying your device's class against CDSCO's published classification list is the essential first step before any application begins.
Non-invasive diagnostic and examination aids with minimal patient risk. Non-sterile, non-measuring category.
Devices contacting the eye surface or measuring ocular parameters; may be sterile.
Invasive surgical systems, implantable devices, and intraocular materials with significant risk profile.
Highest risk class in ophthalmic devices — replacement of critical ocular fluids.
Ophthalmic Device Examples by CDSCO Class
CDSCO has published a detailed classification list for ophthalmic medical devices. The following examples illustrate the range of devices in each class and help manufacturers and importers position their products correctly before approaching the SUGAM portal.
- Amsler grid
- Diagnostic condensing lens
- Electronic occlusion spectacles
- Enucleation scissors
- Exophthalmometer
- Eye cup / eye irrigation shield / eye pad
- Eyelid clamp / eyelid weight (external)
- Fresnel lens / Fresnel prism
- Hand-held telescope
- Indirect binocular ophthalmoscope
- Ophthalmic caliper / distometer
- Ophthalmic suture scissors
- Orbital depressor
- Surgical binoculars
- Visual chart / visual light box / visual projector
- Contact lens inserter / remover
- Colour discrimination tester
- Automated lensmeter (dioptometer)
- Nystagmus inducing optokinetic drum
- Visual evoked-potential electrode
- Corneal burr (abrasion / rust ring removal)
- Corneal epithelium perforator / trephine
- Corneal light shield / corneal marker
- Corneal scissors / corneal resection holder
- Eye heat therapy pack
- Eye muscle clamp
- Epiretinal / inner limiting membrane scraper
- Intraocular lens guide
- Keratome
- Keratoscope
- Ophthalmic refractometer
- Ophthalmic tonometer
- Ophthalmic ultrasound imaging system
- Ophthalmoscope
- Scleral marker
- Ultrasound pachymeter
- Corneal inlay — aperture reducing
- Corneal inlay — cornea-reshaping
- Donor cornea container
- Endoscopic-imaging ophthalmic solid-state laser
- Eye muscle sleeve / eye valve
- Eyelid weight (implantable)
- Femtosecond ophthalmic solid-state laser system
- Fundus-imaging ophthalmic laser systems
- Glaucoma supraciliary implant
- Intracorneal ring
- Intranasal lacrimal neurostimulator
- Intraocular fluid
- Lacrimal tube / ophthalmic clip
- Ophthalmic excimer laser system
- Ophthalmic noble gas laser system
- Orbital rim prosthesis
- Phacoemulsification system
- Ptosis sling / retinal tack
- Scleral buckling device / scleral expansion implant
- Symblepharon ring
- Vitrectomy system
- Vitreous body prosthesis
- Aqueous humour replacement medium kit
- Vitreous humour replacement medium kit
GSR 102(E): The Registration-to-Licensing Transition You Must Know
Prior to October 2023, Class C and D ophthalmic medical devices could be placed on the Indian market under a CDSCO registration certificate. That changed with the implementation of GSR 102(E) dated 11 February 2020, which transitioned these higher-risk devices from a registration-based framework to a full licensing regime under MDR 2017.
The GSR 102(E) transition reflects CDSCO's broader regulatory maturation — aligning India's approach to higher-risk medical devices with international frameworks such as the EU MDR and US FDA 510(k)/PMA pathways. The licensing regime requires more rigorous technical documentation, imposes ISO 13485 as a mandatory prerequisite, and enables CDSCO to conduct facility inspections before granting production approval. For compliant manufacturers, this transition creates a meaningful barrier to entry that protects their market position and reinforces their quality credentials.
Licensing Pathways: MD5, MD9, and MD15
Your ophthalmic device's CDSCO class determines which of three licensing pathways applies. Each has a different form, a different licensing authority, different fees, and different technical documentation requirements.
- Application form: Form MD3
- Issuing authority: State Licensing Authority (SLA)
- Portal: SUGAM — cdscoonline.gov.in
- Covers ophthalmoscopes, tonometers, corneal instruments, visual charts, diagnostic lenses, eye cups, ultrasound imaging systems, refractometers
- Standard documentation review by SLA; facility inspection possible
- Valid indefinitely — 5-year retention fee
- Loan license (no own facility): MD6 via Form MD4
- Application form: Form MD7
- Issuing authority: Central Licensing Authority (CLA — CDSCO)
- Portal: SUGAM — cdscoonline.gov.in
- Covers phacoemulsification systems, vitrectomy systems, excimer and femtosecond lasers, corneal inlays, retinal tacks, glaucoma implants, intraocular fluid, aqueous/vitreous humour replacement kits
- Intensive CLA review — includes biocompatibility data, sterilisation validation, clinical performance evidence, and for Class D: full toxicological assessment
- Valid indefinitely — 5-year retention fee
- Loan license (no own facility): MD10 via Form MD10
CDSCO Ophthalmic Device License Fee Structure
CDSCO's fee structure for ophthalmic medical device licenses is fixed under MDR 2017 and payable through the SUGAM portal at the time of application. The fee varies by license type and is supplemented by a per-device fee for each distinct ophthalmic device product listed in the application.
CDSCO Regulatory Framework for Ophthalmic Medical Devices — At a Glance
| Regulatory Parameter | Class A & B Ophthalmic Devices | Class C & D Ophthalmic Devices |
|---|---|---|
| Regulatory framework | Medical Devices Rules, 2017 (MDR 2017) | |
| GSR 102(E) transition | Not applicable (always licensed) | Registration → Licensing from 1 Oct 2023 |
| Manufacturing license | MD5 | MD9 |
| Application form | Form MD3 | Form MD7 |
| Licensing authority | State Licensing Authority (SLA) | Central Licensing Authority (CLA — CDSCO) |
| Application portal | SUGAM — cdscoonline.gov.in | |
| License fee | ₹5,000 + ₹500/device | ₹50,000 + ₹1,000/device |
| Loan license (no facility) | MD6 · Form MD4 | MD10 · Form MD10 |
| Import license (all classes) | MD15 · Form MD14 · Central Licensing Authority | |
| License validity | Indefinite — subject to 5-year retention fee | |
| ISO 13485 mandatory | Yes — for all manufacturing license applications | |
| Biocompatibility data required | Contact lens devices / sterile Class B | Yes — all Class C and D devices |
| Free Sale Certificate (import) | May be required | Required from FDA/EU/Japan/Australia/Canada |
Document Checklist for CDSCO Ophthalmic Medical Device Registration
Every document in your dossier must be current, internally consistent, and precisely matched to the ophthalmic device types listed in your SUGAM application. For MD9 applications covering Class C/D ophthalmic devices, the technical depth required — particularly biocompatibility data, sterilisation validation, and clinical performance evidence — is significantly greater than for MD5 applications.
- Cover letter addressed to the correct authority — SLA for MD5 (Class A/B) or CLA for MD9 (Class C/D) — with complete applicant details, facility address, and ophthalmic device types applied for
- Organisation identity proof — UDYAM Aadhaar registration, PAN card, or equivalent
- Constitution proof — GST Certificate, Certificate of Incorporation (CIN), Memorandum and Articles of Association (MOA/AOA)
- Sale Deed or Rent/Lease Deed of the manufacturing premises proving legal occupation at the address stated in the application
- Plant Master File (PMF) — complete description of the manufacturing facility: infrastructure, equipment, environmental controls, cleanroom classification (if applicable), QMS overview, and GMP compliance documentation
- Device Master File (DMF) — full technical documentation for each ophthalmic device type: intended use, design specifications, bill of materials, manufacturing process, biocompatibility evaluation, risk analysis, and QC specifications
- Certificate of Analysis for 3 consecutive production batches — covering every ophthalmic device type in the application, demonstrating that finished products meet all specified quality and performance parameters
- Dimensioned building layout plan — technical drawings showing room-by-room equipment locations, cleanroom areas (ISO class where applicable), material flow paths, and personnel flow
- Personnel qualification documents — educational qualifications, work experience records, and training logs for manufacturing and QC staff
- Test License (if applicable) — if pilot or validation batches of ophthalmic devices have been manufactured prior to the full commercial manufacturing license application
- ISO 13485 certificate — valid, issued by an accredited body, with scope explicitly covering the ophthalmic device categories applied for
- Fire NOC — from the local fire authority for the manufacturing premises
- Pollution NOC — from the state pollution control board
- Biocompatibility evaluation reports (Class B contact devices and all Class C/D) — ISO 10993-series testing data or risk-based biocompatibility assessment for devices contacting the eye, cornea, or intraocular tissues
- Sterilisation validation records (all sterile ophthalmic devices) — demonstrating a validated sterilisation process achieving Sterility Assurance Level (SAL) of 10⁻⁶ for surgical instruments, implants, and ophthalmic surgical systems
- Clinical performance evidence (Class C/D — MD9 only) — technical data supporting safety and performance claims for surgical laser systems, intraocular implants, and humour replacement products
- Free Sale Certificates (MD15 import, Class C/D) — from recognised regulatory bodies (US FDA, EU, Japan TGA, Australia TGA, Health Canada) confirming international market approval
How to Prepare the CDSCO Plant Master File in 2026
Learn what every section of the CDSCO Plant Master File must contain, how inspectors use it during facility audits, and the 10-step preparation process that produces an inspection-ready PMF for your MD5 or MD9 application.
7-Step CDSCO License Application Process for Ophthalmic Medical Devices
Here is the complete application pathway — from classification confirmation to license receipt — with the specific actions at each stage that determine whether your application moves efficiently or generates costly delays.
Before opening the SUGAM portal, verify the CDSCO classification for every ophthalmic device you intend to manufacture or import. Use CDSCO's published medical device classification list. For ophthalmic devices, pay particular attention to the boundary between Class B (contact devices) and Class C (invasive or implantable devices) — this boundary determines whether you file Form MD3 with the SLA or Form MD7 with the CLA. Filing the wrong form to the wrong authority results in rejection and restarts the timeline. If your device is not on the published list, obtain a formal classification determination from CDSCO before proceeding.
Create or sign in to your account on the CDSCO SUGAM portal at cdscoonline.gov.in. Confirm that your entity name, PAN number, and contact details exactly match your GST certificate and corporate identity documents. Discrepancies between the SUGAM account and supporting documents — even minor spelling variations in company name — generate automatic system queries that add preventable delays at the submission stage.
For Class A/B ophthalmic devices, complete Form MD3 for the MD5 license. For Class C/D ophthalmic devices, complete Form MD7 for the MD9 license. For importing ophthalmic devices, complete Form MD14 for the MD15 license. Every field — device class, ophthalmic device category name, intended use, facility address, and manufacturer details — must be completed accurately and must match your Device Master File, ISO 13485 certificate, and batch CoA in every specific. The most common cause of SLA and CLA queries in ophthalmic device applications is a mismatch between the Form MD7 device description and the technical specifications in the DMF.
Prepare and upload all supporting documents through SUGAM. For Class C/D MD9 applications, ensure biocompatibility data is complete and covers all tissue contact categories relevant to your ophthalmic device (ISO 10993 series); sterilisation validation records demonstrate SAL 10⁻⁶; and clinical performance evidence is technically substantive. Check that your ISO 13485 certificate scope explicitly names ophthalmic devices or the surgical/medical device category your products fall into. A scope that says only "medical devices" without specifying ophthalmic applications may generate a CLA query requiring an updated certificate.
Pay the prescribed CDSCO application fee through SUGAM: Rs. 5,000 plus Rs. 500 per device for MD5; Rs. 50,000 plus Rs. 1,000 per device for MD9. If applying for multiple distinct ophthalmic device types under a single application, calculate the total per-device fee accurately before submitting. Payment is made digitally and must be completed before formal submission. Retain the payment confirmation receipt in your license file.
The SLA (MD5) or CLA (MD9) reviews your submitted application and documents. For Class C/D ophthalmic devices, the CLA review is comprehensive — including technical assessment of biocompatibility data for intraocular materials, sterilisation validation for surgical instruments, laser system performance specifications, and clinical evidence for implantable ophthalmic devices. Monitor your SUGAM dashboard actively. Respond to every query completely and with supporting documentary evidence within the response window. For MD9 ophthalmic applications, CLA queries may require substantive technical responses rather than simple document substitutions — plan for this in your timeline.
CDSCO or the SLA may schedule an on-site inspection of your ophthalmic device manufacturing facility, particularly for Class C/D surgical and implantable products where cleanroom conditions, sterilisation equipment, and laser safety infrastructure are critical. Ensure your Plant Master File accurately describes the facility as it currently exists — inspectors cross-check physical conditions, equipment records, and personnel qualifications against the PMF. Run a thorough internal pre-inspection audit before the official visit. Once all criteria are satisfied, the license is issued. Verify every detail on the MD5 or MD9 license — device names, class, facility address, and CLA or SLA reference — before commencing commercial production or distribution.
Frequently Asked Questions
What is the difference between MD9 and MD15 for ophthalmic devices?
The MD9 license is for manufacturing Class C and D ophthalmic devices in India, applied via Form MD7 to the Central Licensing Authority. The MD15 license is for importing ophthalmic devices of any class into India, applied via Form MD14 to the Central Licensing Authority. A company that both manufactures in India and imports additional products requires both licenses. Foreign manufacturers who export ophthalmic devices to India do not need an MD9 — their Indian authorised agent applies for the MD15 import license on their behalf.
What does the GSR 102(E) transition mean for existing ophthalmic device registrations?
GSR 102(E) dated 11 February 2020 transitioned Class C and D medical devices — including ophthalmic devices such as phacoemulsification systems, vitrectomy systems, and laser platforms — from CDSCO's earlier registration mechanism to a full licensing regime under MDR 2017. This transition took effect from 1 October 2023. Any company that was distributing Class C/D ophthalmic devices in India on the basis of a legacy CDSCO registration certificate (rather than an MD9 or MD15 license) needed to obtain the applicable license by that date. Post-October 2023, operating without the applicable license is a regulatory violation.
Is ISO 13485 mandatory for ophthalmic device registration in India?
Yes. ISO 13485 certification is mandatory for all CDSCO MD5 and MD9 manufacturing license applications, including all ophthalmic medical devices. The certificate must be current, issued by an accredited certification body, and explicitly scoped to the ophthalmic or medical device categories you intend to manufacture. A scope mismatch between the ISO 13485 certificate and the device types applied for is one of the most frequent query triggers in ophthalmic device MD9 applications reviewed by the CLA.
Do Free Sale Certificates from other countries help with CDSCO MD15 ophthalmic device import registration?
Yes — and for Class C and D ophthalmic devices, they are typically required. CDSCO's MD15 import license process for higher-risk ophthalmic devices requires Free Sale Certificates from recognised global regulatory bodies — specifically the US FDA, the European Union, Japan's PMDA, Australia's TGA, or Health Canada. These certificates serve as evidence that the device meets international quality and safety standards and is freely available in its country of approval. The requirement reflects CDSCO's alignment with international regulatory convergence for high-risk medical devices.
Can a single MD9 license cover multiple Class C ophthalmic device types?
Yes. A single MD9 license can cover multiple Class C and/or D ophthalmic device types manufactured at the same facility, provided each product is listed in the Form MD7 application and the Device Master File includes product-specific documentation — intended use, specifications, manufacturing process, biocompatibility data, and QC programme — for each. Adding new ophthalmic device types after the initial license grant requires a variation application to the CLA, not a new MD9 license application.
✓ Key Takeaways
- Ophthalmic medical devices in India are regulated under MDR 2017 and classified into four risk classes — A, B, C, and D — based on invasiveness, intended tissue contact, and risk to vision
- Class A and B ophthalmic devices (visual charts, ophthalmoscopes, tonometers, corneal instruments) require the MD5 license via Form MD3 — fees Rs. 5,000 + Rs. 500/device — from the State Licensing Authority
- Class C and D ophthalmic devices (phacoemulsification systems, vitrectomy systems, excimer lasers, corneal inlays, aqueous humour replacement kits) require the MD9 license via Form MD7 — fees Rs. 50,000 + Rs. 1,000/device — from the Central Licensing Authority
- Importers of ophthalmic devices of any class require the MD15 import license (Form MD14) from the CLA; Class C/D imports require Free Sale Certificates from US FDA, EU, Japan, Australia, or Canada
- Under GSR 102(E) dated 11 February 2020, Class C and D ophthalmic devices transitioned from registration to licensing — effective from 1 October 2023. Legacy registration certificates are no longer sufficient for market compliance
- All applications are filed through the SUGAM portal at cdscoonline.gov.in
- Licenses are valid indefinitely but require a five-year retention fee to remain active
- ISO 13485 certification is mandatory — the certificate scope must explicitly cover the ophthalmic device categories being manufactured
- Class C/D MD9 applications require biocompatibility data (ISO 10993), sterilisation validation, and clinical performance evidence — plan documentation preparation well before portal submission
- Confirm your device's CDSCO class before opening SUGAM — filing the wrong form to the wrong authority restarts the timeline from zero
Your Next Step
CDSCO registration for ophthalmic medical devices in India is a clearly structured process in 2026 — but it is not a simple one, particularly for Class C and D surgical and implantable devices. The GSR 102(E) transition has raised the regulatory bar for higher-risk ophthalmic products, and the CLA review for MD9 applications is thorough. Manufacturers and importers who invest in rigorous documentation — a complete Device Master File specific to each ophthalmic product, an ISO 13485 certificate correctly scoped, robust biocompatibility and sterilisation validation records — consistently achieve smoother, faster application outcomes than those who submit quickly and manage queries reactively.
The commercial opportunity in India's ophthalmic device market is substantial and growing. The regulatory pathway is demanding but navigable. The two need to be planned together from the outset.
Speak to a Rego Services regulatory consultant today to confirm your ophthalmic device's CDSCO class, identify the correct license pathway, and build a documentation strategy that produces a complete, query-ready application from first submission.